Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.

Nathan S., Behr J., Collard H., Cottin V., Hoeper M., Martinez F., ...More

The Lancet. Respiratory medicine, vol.7, pp.780-790, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2019
  • Doi Number: 10.1016/s2213-2600(19)30250-4
  • Title of Journal : The Lancet. Respiratory medicine
  • Page Numbers: pp.780-790